Back to search
Autoimmune Polyglandular Syndrome Type I
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Polyglandular Syndrome Type I trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Polyglandular Syndrome Type I trials you may qualify forBackground: \- The immune system is made up of special cells, tissues, and organs that fight infections. Problems with this system may lead to frequent, severe…
Background: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), also known as Autoimmune polyendocrine syndrome type-1 (APS-1), is a disea…
Background: Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) is a problem of the immune system. In people with APECED, the immune system…
The main objective of this study is to generate diagnosis and therapeutic-decision tools through the identification of molecular causes of PIDs with autoimmunit…
Studying genetic predisposition in autoimmune neurological diseases could help improve diagnostic accuracy and offer new treatment possibilities
This randomized crossover study will evaluate the safety, efficacy, and pharmacodynamics of synthetic human PTH 1-34 (PTH) delivered by an insulin pump (omnipod…
The goal of this clinical trial is to explore if a telehealth music therapy intervention helps with quality of life, depression symptoms, anxiety symptoms. It w…